UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 6, 2013 10:00 A.M.

Form:	F-1
CIK: 0001541157 Company Name: Celsus Therapeutics Plc. File Number: 333-191880